Clinical Trial Update: Effect of Bromocriptine on Insulin Resistance in Polycystic Ovarian Syndrome - A Pilot Study [Phase 3]

View source ↗

Summary

A Phase 3 pilot clinical trial is evaluating bromocriptine for insulin resistance in polycystic ovary syndrome, with the study status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Polycystic Ovary Syndrome

Drugs mentioned

• Bromocriptine (bromocriptine)

Snippet

Sponsor: IWK Health Centre | Conditions: PCOS, Insulin Resistance | Phase 3 | Status: UNKNOWN